2017 Speakers

In 2017, the discussion was led by 100 speakers from pharma, biotechs, governments, hospitals, and academia.

Maria Ascano, Director, Infectious, Niche, and Rare Diseases, Decision Resources Group

Maria Ascano at World Anti-Microbial Resistance Congress 2017

Ritu Banerjee, Associate Professor of Pediatrics, Vanderbilt Antimicrobial Stewardship Program (VASP)

Ritu Banerjee at World Anti-Microbial Resistance Congress 2017

Heather Behanna, Principal, Sofinnova Ventures

Heather Behanna at World Anti-Microbial Resistance Congress 2017

Daniel Berman, Lead, Longitude Prize, Nesta

Daniel Berman at World Anti-Microbial Resistance Congress 2017

Todd Black, Executive Director, Infectious Diseases, Merck Research Laboratory

Todd Black at World Anti-Microbial Resistance Congress 2017

Cara Cassino, Chief Medical Officer and Executive Vice President of Research and Development, Contrafect Corporation

Cara Cassino at World Anti-Microbial Resistance Congress 2017

Manu Chaudhary, Joint Managing Director and Director of Research, Venus Remedies Ltd

Manu Chaudhary at World Anti-Microbial Resistance Congress 2017

Ami Claxton, Global Director, Health Economics and Outcomes Research, BioMerieux

Ami Claxton at World Anti-Microbial Resistance Congress 2017

Oren Cohen, Chief Medical Officer, Viamet Pharmaceuticals

Oren Cohen at World Anti-Microbial Resistance Congress 2017

Timothy Cooke, Chief Executive Officer, NovaDigm Therapeutics

Timothy Cooke at World Anti-Microbial Resistance Congress 2017

Ian Critchley, VP Clinical Microbiology, Allergan Pharmaceuticals Inc

Ian Critchley at World Anti-Microbial Resistance Congress 2017

Glenn Dale, Head of Early Development, Antimicrobials, Polyphor Ltd

Glenn Dale at World Anti-Microbial Resistance Congress 2017

Paul Andre De Lame, Chief Medical Officer, Aridis Pharmaceuticals

Paul Andre De Lame at World Anti-Microbial Resistance Congress 2017

Enea Di Domenico, Clinical Pathology and Microbiology, Istituti Fisioterapici Ospitalieri

Enea Di Domenico at World Anti-Microbial Resistance Congress 2017

Elizabeth Dodds Ashley, Clinical Pharmacist Duke Antibiotic Stewardship Outreach Network (DASON), Duke University

Elizabeth Dodds Ashley at World Anti-Microbial Resistance Congress 2017

Oreola Donini, Chief Scientific Officer, Soligenix

Oreola Donini at World Anti-Microbial Resistance Congress 2017

Brian Dorsey, Founding Partner, Magnasci Ventures

Brian Dorsey at World Anti-Microbial Resistance Congress 2017

Michael Draper, Extneral Innovation, Sanofi

Michael Draper at World Anti-Microbial Resistance Congress 2017

Michael Dudley, Senior Vice President, Head of R&D Co-Lead, Infectious Disease Global Innovation, The Medicines Company

Michael Dudley at World Anti-Microbial Resistance Congress 2017

Barry Eisenstein, Chair, Scientific Advisory Board, CARB-X

Barry Eisenstein at World Anti-Microbial Resistance Congress 2017

Scott Evans, Director, Statistical and Data Management Center (SDMC) for the Antibacterial Resistance Leadership Group (ARLG), Harvard University

Scott Evans at World Anti-Microbial Resistance Congress 2017

Kevin Finney, Chief Operating Officer, Zavante Therapeutics, Inc.

Kevin Finney at World Anti-Microbial Resistance Congress 2017

William Fried, Senior Medical Director, Aetna

William Fried at World Anti-Microbial Resistance Congress 2017

Jean-Marc Ghigo, Head of Genetics of Biofilms Lab, Institut Pasteur

Jean-Marc Ghigo at World Anti-Microbial Resistance Congress 2017

Debra Goff, Infectious Diseases Specialist,The Ohio State University Wexner Medical Center Clinical Associate Professor, The Ohio State University Medical Center

Debra Goff at World Anti-Microbial Resistance Congress 2017

Keith Hamilton, Director, Antimicrobial Stewardship Program, Hospital of the University of Pennsylvania

Keith Hamilton at World Anti-Microbial Resistance Congress 2017

Janet Hammond, Vice President Infectious Diseases, AbbVie

Janet Hammond at World Anti-Microbial Resistance Congress 2017

Evan Hecker, Director of API Development, Spero Therapeutics LLC

Evan Hecker at World Anti-Microbial Resistance Congress 2017

Elizabeth Hermsen, Head, Global Antimicrobial Stewardship, Merck & Co., Inc.

Elizabeth Hermsen at World Anti-Microbial Resistance Congress 2017

Lauri Hicks, Director, Office of Antibiotic Stewardship, Division of Healthcare Quality Promotion, Centers for Disease Control & Prevention

Lauri Hicks at World Anti-Microbial Resistance Congress 2017

Jennifer Hoover, Chief Scientist, Antibacterial DPU Infectious Disease Therapy Area Unit, GSK

Jennifer Hoover at World Anti-Microbial Resistance Congress 2017

Chris Houchens, PhD, Branch Chief (Acting), Antibacterials Program, BARDA

Chris Houchens at World Anti-Microbial Resistance Congress 2017

Romney Humphries, Section Chief,Clinical Microbiology, Ucla Health System University of California Los Angeles

Romney Humphries at World Anti-Microbial Resistance Congress 2017

Deborah Hung, Director of Infectious Disease Program, Broad Institute of M.I.T. & Harvard

Deborah Hung at World Anti-Microbial Resistance Congress 2017

Peter Jackson, CEO, The AMR Centre UK

Peter Jackson at World Anti-Microbial Resistance Congress 2017

Brendan Jackson, Epidemiology Team Lead, Mycotic Diseases Branch, C.D.C

Brendan Jackson at World Anti-Microbial Resistance Congress 2017

Amanda Jezek, Senior VP, Public Policy and Government Relations, Infectious Diseases Society of America

Amanda Jezek at World Anti-Microbial Resistance Congress 2017

Mark E. Jones, Head of Project Management, Basilea Pharmaceutica Ltd

Mark E. Jones at World Anti-Microbial Resistance Congress 2017

Christopher Jones, Acting Associate Deputy Assistant Secretary, U.S. Department of Health & Human Services

Christopher Jones at World Anti-Microbial Resistance Congress 2017

Lee Jones, Founder, President and Chief Executive Officer, Rebiotix, Inc.

Lee Jones at World Anti-Microbial Resistance Congress 2017

Adrian Jubb, Vice President and Head of Early Development, Achaogen

Adrian Jubb at World Anti-Microbial Resistance Congress 2017

Ciara Kennedy, Chief Executive Officer, Amplyx Pharmaceuticals, Inc

Ciara Kennedy at World Anti-Microbial Resistance Congress 2017

Jane Knisely, Program Officer, Bacteriology and Mycology Branch, NIAID, NIH - NIAID & University of Kansas

Jane Knisely at World Anti-Microbial Resistance Congress 2017

John Kokai-Kun, Vice President of Non-Clinical Affairs, Synthetic Biologics Inc

John Kokai-Kun at World Anti-Microbial Resistance Congress 2017

Sophia Koo, Assistant Professor of Medicine, Harvard Medical School

Sophia Koo at World Anti-Microbial Resistance Congress 2017

Nicole Mahoney, Director, Global Regulatory Policy, Merck

Nicole Mahoney at World Anti-Microbial Resistance Congress 2017

Valerie Oriol Mathieu, Global Medical Affairs Lead, Vaccines, Janssen Vaccines & Prevention

Valerie Oriol Mathieu at World Anti-Microbial Resistance Congress 2017

Andrew McCandlish, Director, Corporate Development, Achaogen

Andrew McCandlish at World Anti-Microbial Resistance Congress 2017

Clive Meanwell, Chief Executive Officer, The Medicines Company

Clive Meanwell at World Anti-Microbial Resistance Congress 2017

Tyler Merkeley, Program Manager, CARB-X

Tyler Merkeley at World Anti-Microbial Resistance Congress 2017

Pierre Meulien, Executive Director of Innovative Medicines Initiative, Innovative Medicines Initiative

Pierre Meulien at World Anti-Microbial Resistance Congress 2017

Donald Moir, Chief Scientific Officer, Microbiotix Inc

Donald Moir at World Anti-Microbial Resistance Congress 2017

Gareth Morgan, Senior Vice President, Global Portfolio Management, Shionogi Inc

Gareth Morgan at World Anti-Microbial Resistance Congress 2017

Jason Newland, Director of Antimicrobial Stewardship Program, Washington University in St. Louis

Jason Newland at World Anti-Microbial Resistance Congress 2017

Deborah O'Neil, Chief Executive & Scientific Officer, NovaBiotics Ltd

Deborah O'Neil at World Anti-Microbial Resistance Congress 2017

Thomas Oullette, Executive Director of Marketing, Tetraphase Pharmaceuticals Inc

Thomas Oullette at World Anti-Microbial Resistance Congress 2017

Jean Patel, Deputy Director, Office of Antimicrobial Resistance, Center for Disease Control & Prevention

Jean Patel at World Anti-Microbial Resistance Congress 2017

David Paterson, Professor Of Medicine, University Of Queensland Centre For Clinical Research

David Paterson at World Anti-Microbial Resistance Congress 2017

Erik Paulsen, Congressman, United States House Of Representatives

Erik Paulsen at World Anti-Microbial Resistance Congress 2017

David Payne, VP Antibacterial Discovery Performance Unit, GlaxoSmithKline

David Payne at World Anti-Microbial Resistance Congress 2017

Manos Perros, President & CEO, Entasis Therapeutics

Manos Perros at World Anti-Microbial Resistance Congress 2017

Yannick Pletan, Senior Consultant, ULTRACE

Yannick Pletan at World Anti-Microbial Resistance Congress 2017

William Powderly, President, Infectious Diseases Society of America

William Powderly at World Anti-Microbial Resistance Congress 2017

Aleks Radovic-Moreno, Senior Associate, PureTech Health

Aleks Radovic-Moreno at World Anti-Microbial Resistance Congress 2017

Joshua Resnick, Partner, S.V. Life Sciences

Joshua Resnick at World Anti-Microbial Resistance Congress 2017

Josh Richardson, Managing Director, Longitude Capital

Josh Richardson at World Anti-Microbial Resistance Congress 2017

Jeffrey Riley, Chief Executive Officer, Director and President, Synthetic Biologics

Jeffrey Riley at World Anti-Microbial Resistance Congress 2017

Robert P Sambursky, Founder, President & Chief Technical/Medical Officer, Rapid Pathogen Screening, Inc (RPS)

Robert P Sambursky at World Anti-Microbial Resistance Congress 2017

Tharini Sathiamoorthy, Vice President, AdvaMedDx

Tharini Sathiamoorthy at World Anti-Microbial Resistance Congress 2017

Paul Schaper, Executive Director, Global Health Policy, Merck Sharp & Dohme

Paul Schaper at World Anti-Microbial Resistance Congress 2017

Monika Schneider, Research Associate, Margolis Center for Health Policy, Duke University

Monika Schneider at World Anti-Microbial Resistance Congress 2017

Susan Sharp, Past President, American Society For Microbiology

Susan Sharp at World Anti-Microbial Resistance Congress 2017

Ribhi Shawar, Branch Chief, Division of Microbiology, CDRH OIR FDA

Ribhi Shawar at World Anti-Microbial Resistance Congress 2017

Henry Skinner, Managing Director, Novartis Venture Fund

Henry Skinner at World Anti-Microbial Resistance Congress 2017

Joseph Sliman, Senior Vice President, Clinical and Regulatory Affairs, Synthetic Biologics Inc

Joseph Sliman at World Anti-Microbial Resistance Congress 2017

Brad Spellberg, Chief Medical Officer, Keck School of Medicine of U.S.C.

Brad Spellberg at World Anti-Microbial Resistance Congress 2017

Jeff Stein, President and Chief Executive Officer, Cidara Therapeutics

Jeff Stein at World Anti-Microbial Resistance Congress 2017

Chris Stevens, Chief Medical Officer, Arsanis Inc

Chris Stevens at World Anti-Microbial Resistance Congress 2017

Melissa Stundick, Head of Strategic Alliances, Spero Therapeutics LLC

Melissa Stundick at World Anti-Microbial Resistance Congress 2017

Dolca Thomas, Vice President and Head of Translational Medicine for Immunology and Inflammation and Infectious Disease, Roche

Dolca Thomas at World Anti-Microbial Resistance Congress 2017

Joe Thomas, Associate, Antibiotic Resistance Project, Pew Charitable Trusts

Joe Thomas at World Anti-Microbial Resistance Congress 2017

Brian Tse, Health Scientist, HHS/BARDA

Brian Tse at World Anti-Microbial Resistance Congress 2017

Daniel Uslan, Director, Antimicrobial Stewardship Program, Division of Infectious Diseases, U.C.L.A. Health

Daniel Uslan at World Anti-Microbial Resistance Congress 2017

David Visi, Senior Associate, Antibiotic Resistance Project, The Pew Charitable Trusts

David Visi at World Anti-Microbial Resistance Congress 2017

Jeffrey Wager, Chairman & CEO, EnBiotix Inc

Jeffrey Wager at World Anti-Microbial Resistance Congress 2017

Bernhardt Zeiher, President, Global Development, Astellas Pharma Global Development Inc

Bernhardt Zeiher at World Anti-Microbial Resistance Congress 2017

Barbara Zimmer, Principal Scientist, Scientific Affairs, Beckman Coulter

Barbara Zimmer at World Anti-Microbial Resistance Congress 2017

Zachary Zimmerman, CEO, Forge Therapeutics

Zachary Zimmerman at World Anti-Microbial Resistance Congress 2017

 

If you are interested in speaking at our 2018 conference, contact André Singer at +1 646 619 1797 or andre.singer@terrapinn.com now!

 

SIGN UP FOR EVENT UPDATES